News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tetra Bio-Pharma
(OP:
TBPMF
)
N/A
UNCHANGED
Last Price
Updated: 1:28 PM EDT, Sep 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tetra Bio-Pharma
< Previous
1
2
3
4
Next >
Cannabis Stock Movers For July 24, 2023
July 24, 2023
Via
Benzinga
Cannabis Stock Movers For July 21, 2023
July 21, 2023
Via
Benzinga
Akanda To Supply Tetra Bio-Pharma With Cannabis For FDA Trials Of Cancer-Pain Drug
July 12, 2022
Akanda Corp.
Via
Benzinga
Cannabis Stock Movers For July 20, 2023
July 20, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 18, 2023
July 18, 2023
Via
Benzinga
Cannabis Stock Movers For July 19, 2023
July 19, 2023
Via
Benzinga
Marijuana Stock Movers For July 17, 2023
July 17, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 14, 2023
July 14, 2023
Via
Benzinga
Bullish Thursday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
July 13, 2023
Via
Benzinga
Marijuana Stock Movers For July 12, 2023
July 12, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 11, 2023
July 11, 2023
Via
Benzinga
Tetra Bio-Pharma Receives Funding from the Government of Canada for ARDS-003
March 03, 2023
The Company is receiving up to $150,000 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the development of its novel oral...
Via
TheNewswire.com
Exposures
COVID-19
Tetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements and Related Management's Discussion and Analysis
March 01, 2023
MONTREAL, QUEBEC – TheNewswire – March 1, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and...
Via
TheNewswire.com
AI Study: Synthetic Cannabinoid + Favipiravir Presents Viable Treatment Against Viral Infections, Including COVID
December 06, 2022
Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1), announced results from the study of Onternabez combined with Favipiravir against ARDS (acute respiratory distress syndrome), sepsis, and...
Via
Benzinga
Tetra Bio-Pharma Announces Second Closing Of Financing With Alpha Blue Ocean
October 28, 2022
Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1), has closed the second tranche of its financing arrangement with Global Corporate Finance Opportunities 16, an investment vehicle advised by...
Via
Benzinga
Preclinical Trial Results Confirm Targeting Type 2 Cannabinoid Receptors Helps Relieve Sepsis-Related Condition
August 10, 2022
Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1) revealed positive preclinical results from live SARS-CoV-2 virus infection studies as well as a septic lung model, carried out by independent...
Via
Benzinga
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
July 12, 2022
From
Akanda Corp. and Tetra Bio-Pharma
Via
Business Wire
Tetra Bio-Pharma Opens New Subsidiary In Australia And Provides Regulatory Update
June 06, 2022
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: TBPMF) (FRA:JAM1) launched new wholly owned subsidiary 'Tetra Bio-Pharma Australia Pty Ltd', an Australian-based research company focused on the execution of...
Via
Benzinga
Tetra Bio-Pharma Receives EMA Orphan Drug Designation For A Novel Topical Therapeutic Containing CBD
May 18, 2022
The European Medicines Agency (EMA) has classified Tetra Bio-Pharma Inc.’s (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1) PPP004 as an orphan medicinal product for the treatment for epidermolysis bullosa (EB).
Via
Benzinga
Tetra Bio-Pharma And Cannvalate Enter Into Partnership
May 05, 2022
Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1) has entered into a research and development agreement with Cannvalate Pty Ltd for the initiation of the REBORN, PLENITUDE and CAUMZ clinical...
Via
Benzinga
Tetra Bio-Pharma Gets Health Canada's Approval To Use 100mg Of CBD In Inhaled Cannabidiol Safety Study
March 08, 2022
Health Canada approved the amendment of a phase I study by Tetra Bio-Pharma Inc. (TSX:
Via
Benzinga
Tetra Bio-Pharma Signs License Agreement With Thorne Health Tech For A Prebiotic Dietary Supplement
February 22, 2022
Tetra Bio-Pharma Inc (TSX:TBP) (OTCQB:
Via
Benzinga
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
February 21, 2022
An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt
Via
Talk Markets
Tetra Bio-Pharma Gets CA$4.5M From Québec's Government To Develop Medicine For ARDS
February 16, 2022
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:
Via
Benzinga
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
February 14, 2022
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:
Via
Benzinga
Psychedelic And Cannabis Drug Stocks Continue Advance
February 13, 2022
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.
Via
Talk Markets
Cannabis Stock Gainers And Losers From January 19, 2022
January 19, 2022
GAINERS: Heritage Cannabis Holding (OTC:
Via
Benzinga
Cannabis Stock Gainers And Losers From January 18, 2022
January 18, 2022
GAINERS: Item 9 Labs (OTC:
Via
Benzinga
Marijuana & Psychedelic Drug Stocks Continue To Decline
January 16, 2022
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are...
Via
Talk Markets
Cannabis Stock Gainers And Losers From January 5, 2022
January 05, 2022
GAINERS: Rhinomed (OTC:
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.